GEODE CAPITAL MANAGEMENT, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$158,294
+81.6%
263,758
+151.2%
0.00%
Q2 2023$87,156
+130.7%
104,9820.0%0.00%
Q1 2023$37,783
+83862.2%
104,982
-1.3%
0.00%
Q4 2022$45
-99.9%
106,3460.0%0.00%
Q3 2022$60,000
-60.3%
106,3460.0%0.00%
Q2 2022$151,000
-64.6%
106,3460.0%0.00%
Q1 2022$426,000
-46.3%
106,346
+11.0%
0.00%
Q4 2021$793,000
+135.3%
95,801
+299.1%
0.00%
Q3 2021$337,00024,0050.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$3,889,0001.78%
Abingworth LLP 4,822,114$2,730,0000.93%
OUP Management Co., LLC 1,025,697$587,0000.91%
Column Group LLC 4,309,329$2,465,0000.55%
Evolution Capital Management LLC 527,885$302,0000.44%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,363,0000.27%
Parallel Advisors, LLC 1,693,559$969,0000.04%
RESOLUTE FINANCIAL, LLC 31,000$18,0000.02%
Oasis Management Co Ltd. 100,000$57,0000.01%
Wescott Financial Advisory Group, LLC 55,556$32,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders